How will your current portfolio fare in 2021?The Chief Global Strategist of J.P. Morgan, Dr. David Kelley, offers his outlook for 2021 and beyond. In these days of COVID, not having a good estate plan can prove costly. Janet Kidd Stewart discusses 13 smart estate planning moves to help you and your heirs keep more of your worth. There are scammers awaiting the vaccine rollout. According to the FTC Consumer Information Division, they may solicit you in a number of ways, as Colleen Tressler reports.

J.P. Morgan’s Investment Outlook — Following a winter slowdown, widespread vaccination should allow U.S. growth to surge later in 2021, precipitating a relatively fast rebound from a deep recession. However, the recoveries for GDP, jobs and inflation are on different timetables with important policy implications. Read more…

13 Smart Estate-Planning Moves — This deadly COVID-19 pandemic continues to raise awareness about the importance of estate planning. “People often underestimate how much it will cost if they don’t plan,” says Renee Fry, founder of Gentreo, an online estate-planning company. Here are 13 ways to create or improve your plan. Read more…

COVID-19 Vaccines Are In The Pipeline. Scammers Won’t Be Far Behind. — While we wait for a timeline and more information on the rollout, there’s no doubt scammers will be scheming. There are a number of ways you may be approached, as Colleen Tressler explains. Read more…

John R. Day, Bill Ennis, Stephanie Hall, and Matt Heller

Disclosure – The articles mentioned in Mid Week with Day & Ennis are for information and educational purposes only. They represent a sample of the numerous articles that the firm reads each week to stay current on financial and economic topics. The articles are linked to websites separate from the Day & Ennis website. The opinions expressed in these articles are the opinions of the author and not Day & Ennis. This is not an offer to buy or sell any security. Day & Ennis is under no obligation to update any of the information in these articles. We cannot attest to the accuracy of the data in the articles.